Insurance problems among inflammatory bowel disease patients: Results of a Dutch population based study

Gut

Volumn 52, Issue 3, 2003, Pages 358-362

  Russel, M G V M ^b   Ryan, B M ^a,b   Dagnelie, P C ^a   De Rooij, M ^b   Sijbrandij, J ^a   Feleus, A ^b   Hesselink, M ^b   Muris, J W ^a   Stockbrugger, R ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INSURANCE COVERAGE; INSURANCE SELECTION BIAS; INSURANCE, HEALTH; INSURANCE, LIFE; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PREJUDICE; PROGNOSIS; REGISTRIES; RISK FACTORS; SMOKING;

EID: 0037372638     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.3.358     Document Type: Article

References (27)

1. Farmer R. The social toll of inflammatory bowel disease. Can J Gastroenterol 1994;8:433-7.
2. Sonnenberg A. Disability and need for rehabilitation among patients with inflammatory bowel disease. Digestion 1992;51:168-78.
3. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997;32:1134-9.
4. Moody GA, Mayberry JF. Life insurance and inflammatory bowel disease: is there discrimination against patients? Int J Colorectal Dis 1996;11:276-8.
5. Travis SP. Review article: insurance risks for patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther 1997;11:51-9.
6. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103:954-60.
7. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
8. Munkholm P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
9. Munkholm P. Crohn's disease - occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44:287-302.
10. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000;35:1272-7.
11. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2-15.
12. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-8.
13. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000;46:336-43.
14. Jess T, Winther KV, Munkholm P, et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002;122:1808-14.
15. Persson PG, Bernell O, Leijonmarck CE, et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996;110:1339-45.
16. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309-17.
17. Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992;14:318-27.
18. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49-57.
19. Russel MG, Dorant E, Volovics A, et al. High incidence of inflammatory bowel disease in the Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum 1998;41:33-40.
20. Russel MG, Dorant E, Brummer RJ, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997;113:377-82.
21. Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24(suppl 170):2-6.
22. Central Bureau voor Statistisch. Statistisch Jaarboek. Heerlen: Voorburg, 2000.
23. Metsemakers J, Hoppener P, Knottenus J, et al. Computerized health information in the Netherlands: a registration network of family practices. Br J Gen Pract 1992;42:102-6.
24. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11.
25. Farrokhyar F, Swarbrick ET, Grace RH, et al. Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England. Am J Gastroenterol 2001;96:501-7.
26. Blomqvist P, Feltelius N, Lofberg R, et al. A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions. Aliment Pharmacol Ther 2001;15:475-81.
27. Eaker S, Bergstrom R, Bergstrom A, et al. Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol 1998;147:74-82.